Engineers Gate Manager LP X4 Pharmaceuticals, Inc Transaction History

Engineers Gate Manager LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.48 - $2.58 $17,573 - $30,634	-11,874 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.9 - $5.6 $22,560 - $66,494	11,874 New	11,874 $27,000
Q3 2021 Nov 15, 2021	SELL	$4.53 - $6.45 $98,817 - $140,700	-21,814 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.49 - $9.56 $141,572 - $208,541	21,814 New	21,814 $142,000

103

99.9M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $41.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.